International Clinical Trial: SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07445789) titled 'SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Martini Hospital Groningen

Condition: Atrial Fibrillation (AF)

Intervention: Drug: Verapamil 240 mg slow-release tablet

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: June 2026

Target Sample Size: 436

To know more, visit...